Motif Bio PLC Result of AGM (6378A)

TIDMMTFB

RNS Number : 6378A

Motif Bio PLC

30 September 2020

Motif Bio plc

("Motif Bio" or the "Company")

Result of AGM

Motif Bio plc (AIM: MTFB) announces that at the Annual General Meeting of the Company held earlier today at the offices of ONE Advisory Limited, 201 Temple Chambers, 3-7 Temple Avenue, London, EC4Y 0DT all but one of the resolutions put to members were passed on a poll.

The Board notes that resolution 7, which was proposed as a special resolution regarding the disapplication of pre-emption rights, was not passed.

The number of votes lodged by proxy and voted on by poll for and against each of the resolutions proposed, and the number of votes withheld, were as follows:

 
 Resolution                       FOR*            %         AGAINST        %         WITHHELD 
 Resolution 1 ( Ordinary 
  ) 
  To receive the Company's 
  annual accounts and the 
  strategic, directors' 
  and auditors' reports 
  for the year ended 31 
  December 2019 .                   37,371,686      91.94     3,275,355      8.06      131,590 
                                 --------------  --------  -------------  --------  ------------ 
 Resolution 2 ( Ordinary 
  ) 
  To re-elect Graham Lumsden 
  as a Director of the 
  Company                           27, 167,596     66.74     13,541,866     33.26     69,169 
                                 --------------  --------  -------------  --------  ------------ 
 Resolution 3 (Ordinary) 
  To re-elect Christopher 
  Wardhaugh as a director 
  of the Company, who was 
  appointed by the board 
  since the last annual 
  general meeting.                  34,740,854      85.42     5,930,684      14.58     107,093 
                                 --------------  --------  -------------  --------  ------------ 
 Resolution 4 (Ordinary) 
  To re-appoint the Company's 
  auditor Crowe LLP, who 
  have been appointed by 
  the board since the last 
  annual general meeting.           37,286,396      91.56     3,437,066      8.44      55,169 
                                 --------------  --------  -------------  --------  ------------ 
 Resolution 5 (Ordinary) 
  That the Directors be 
  authorised to fix the 
  auditors remuneration.            36,844,682      90.71     3,772,431      9.29      161,518 
                                 --------------  --------  -------------  --------  ------------ 
 Resolution 6 ( Ordinary 
  ) 
  To empower the directors 
  to allot relevant securities 
  pursuant to Section 551 
  of the Act                        33,534,192      84.95     5,941,430      15.05     1,303,009 
                                 --------------  --------  -------------  --------  ------------ 
 Resolution 7 ( Special 
  ) 
  To disapply the pre-emptive 
  rights contained in Section 
  561 of the Act                    26,246,162      73.09     9,844,855      26.91     4,187,614 
                                 --------------  --------  -------------  --------  ------------

*including votes granting discretion to the chair

As at 30 September 2020, there were 654,991,023 ordinary shares in issue. Shareholders are entitled to one vote per share. Votes withheld are not votes in law and so have not been included in the calculation of the proportion of votes for and against a resolution.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

For further information please contact:

 
 
   Motif Bio plc                                    ir@motifbio.com 
 Jonathan Gold (President and Chief 
  Business Officer) 
 
 
   SP Angel Corporate Finance LLP (NOMAD 
   & BROKER)                                   +44 (0) 20 3470 0470 
 David Hignell/Caroline Rowe (Corporate 
  Finance) 
 Vadim Alexandre/Abigail Wayne (Sales 
  & Broking) 
 
 Walbrook PR Ltd. (UK FINANCIAL PR 
  & IR)                                        +44 (0) 20 7933 8780 
 Paul McManus/ Lianne Cawthorne             motifbio@walbrookpr.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGBXGDCXDXDGGG

(END) Dow Jones Newswires

September 30, 2020 09:27 ET (13:27 GMT)

Motif Bio (LSE:MTFB)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025